Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5135-30-8

Post Buying Request

5135-30-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5135-30-8 Usage

Chemical Properties

White Crystalline Solid

Uses

Different sources of media describe the Uses of 5135-30-8 differently. You can refer to the following data:
1. 5'-Tosyladenosine is a compound useful in organic synthesis. Adenosine is a naturally occuring nucleoside and an essential building block in DNA synthesis. The tosyl protected adenosine at the 5' position, 5-tosyladenosine, allows for selective functionalistion at the the 3' and 4' positions, resulting in derivatised nucleotides that can incorporated into modified RNA which is an area of therapeutics that is currently expanding.
2. 5’-Tosyl Adenosine (cas# 5135-30-8) is a compound useful in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 5135-30-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,1,3 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5135-30:
(6*5)+(5*1)+(4*3)+(3*5)+(2*3)+(1*0)=68
68 % 10 = 8
So 5135-30-8 is a valid CAS Registry Number.

5135-30-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5'-Tosyl Adenosine

1.2 Other means of identification

Product number -
Other names 5'-Tosyladenosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5135-30-8 SDS

5135-30-8Synthetic route

5'-O-toluenesulphonyl-N6-benzoyladenosine
127246-72-4

5'-O-toluenesulphonyl-N6-benzoyladenosine

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
With ammonia In methanol Ambient temperature;720 mg
With ammonium hydroxide In methanol
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

2.6-dioxy-4-methoxy-benzophenone

2.6-dioxy-4-methoxy-benzophenone

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine
2: aq. NH3 / methanol
View Scheme
N-benzoyladenosine
4546-55-8

N-benzoyladenosine

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine
2: aq. NH3 / methanol
View Scheme
Multi-step reaction with 2 steps
1: pyridine / Ambient temperature
2: 720 mg / ammonia / methanol / Ambient temperature
View Scheme
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / Ambient temperature
2: 720 mg / ammonia / methanol / Ambient temperature
View Scheme
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

N3,5'-cycloadenosine p-toluenesulfonate

N3,5'-cycloadenosine p-toluenesulfonate

Conditions
ConditionsYield
In ethanol for 3h; Heating;96%
2-trimethylsilylethanethiol
18143-30-1

2-trimethylsilylethanethiol

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5'-deoxy-5'-(2-(trimethylsilyl)ethyl)adenosine

5'-deoxy-5'-(2-(trimethylsilyl)ethyl)adenosine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 15h;96%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

8-bromo-5'-O-(p-tolylsulfonyl)adenosine
83316-88-5

8-bromo-5'-O-(p-tolylsulfonyl)adenosine

Conditions
ConditionsYield
With CH3COONa buffer; bromine In methanol for 0.5h; Ambient temperature;89%
N-(2-cyanoethyl)-N-methylamine
693-05-0

N-(2-cyanoethyl)-N-methylamine

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5'-<(2-cyanoethyl)methylamino>-5'-deoxyadenosine
72648-38-5

5'-<(2-cyanoethyl)methylamino>-5'-deoxyadenosine

Conditions
ConditionsYield
at 20℃; for 120h;87%
at 20℃; for 120h;87%
for 120h; Ambient temperature;80%
for 168h; Ambient temperature;42%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5'-deoxyadenosine
4754-39-6

5'-deoxyadenosine

Conditions
ConditionsYield
With lithium triethylborohydride In tetrahydrofuran for 1h; Ambient temperature;86%
With lithium triethylborohydride In tetrahydrofuran at 30℃; for 2h;23 mg
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Coβ-cyano-(adenin-7-yl)cobamide

Coβ-cyano-(adenin-7-yl)cobamide

Coβ-(5'-deoxy-5'-adenosyl)-(adenin-7-yl)cobamide

Coβ-(5'-deoxy-5'-adenosyl)-(adenin-7-yl)cobamide

Conditions
ConditionsYield
Stage #1: Coβ-cyano-(adenin-7-yl)cobamide With tert-butylammonium hexafluorophosphate(V); benzoic acid In methanol at 20℃; for 2h; Electrochemical reaction;
Stage #2: 5'-tosyladenosine In methanol at 20℃; for 2h; Electrochemical reaction;
84.7%
pseudovitamin B12

pseudovitamin B12

water
7732-18-5

water

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

coenzymeβ-(5'-deoxy-5'-adenosyl)-(adenin-7-yl)cobamide

coenzymeβ-(5'-deoxy-5'-adenosyl)-(adenin-7-yl)cobamide

Conditions
ConditionsYield
With benzoic acid In methanol Electrolysis; (N2); electrolysis (-1.1 V vs. 0.1 M calomel electrode) in presence of methanolic soln. of ((C4H9)4N)PF6 and benzoic acid at room temp. for 2 h,addn. of soln. of 5'-O-tosyladenosine in MeOH, electrolysis for 2 h in the dark under stirring; addn. of H2O, extn. with CH2Cl2, evapn. of aq. phase, dissolving in min.amt. of H2O, addn. of acetone, pptn. at 4°C overnight, washing w ith acetone, drying under vac., second pptn. by further addn. of acetone, chromy., drying in vac.;84.7%
p-methoxybenzylmercaptan
6258-60-2

p-methoxybenzylmercaptan

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5′-deoxy-5′-(4-methoxybenzylthio)adenosine
595608-45-0

5′-deoxy-5′-(4-methoxybenzylthio)adenosine

Conditions
ConditionsYield
With N,N,N',N'-tetramethylguanidine for 0.25h; Inert atmosphere; Milling; Sealed tube;84%
tris(tetra-n-butylammonium) hydrogen pyrophosphate
76947-02-9

tris(tetra-n-butylammonium) hydrogen pyrophosphate

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

Conditions
ConditionsYield
In acetonitrile74%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

Conditions
ConditionsYield
With tris(tetra-n-butylammonium) hydrogen pyrophosphate In acetonitrile for 48h; Ambient temperature;74%
tris(tetrabutylammonium) salt of methylenebis(phosphonic acid)
93978-76-8

tris(tetrabutylammonium) salt of methylenebis(phosphonic acid)

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

O5'-(dihydroxyphosphorylmethyl-hydroxy-phosphinoyl)-adenosine
3768-14-7

O5'-(dihydroxyphosphorylmethyl-hydroxy-phosphinoyl)-adenosine

Conditions
ConditionsYield
In acetonitrile for 48h; Ambient temperature;72%
In acetonitrile for 48h;72%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
With tetrakis(tetra-n-butylammonium) hydrogen triphosphate In acetonitrile for 48h; Ambient temperature;72%
tris(tetra-n-butylammonium) hydrogen difluoromethylenediphosphonate
104714-96-7

tris(tetra-n-butylammonium) hydrogen difluoromethylenediphosphonate

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

adenosine-5'-O-α,β-difluoromethylenediphosphate
107201-97-8

adenosine-5'-O-α,β-difluoromethylenediphosphate

Conditions
ConditionsYield
In dimethyl sulfoxide for 1h;65%
In acetonitrile for 66h;54%
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Toluene-4-sulfonic acid (2R,3R,4R,5R)-5-(6-amino-purin-9-yl)-3,4-bis-methanesulfonyloxy-tetrahydro-furan-2-ylmethyl ester

Toluene-4-sulfonic acid (2R,3R,4R,5R)-5-(6-amino-purin-9-yl)-3,4-bis-methanesulfonyloxy-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
In pyridine for 5h;60%
tetrakis(tetra-n-butylammonium) hydrogen triphosphate
93978-77-9

tetrakis(tetra-n-butylammonium) hydrogen triphosphate

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
In acetonitrile for 23h;55%
ethyleneimine
151-56-4

ethyleneimine

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(aziridin-1-ylmethyl)tetrahydrofuran-3,4-diol

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(aziridin-1-ylmethyl)tetrahydrofuran-3,4-diol

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine for 72h; Ambient temperature;24%
With N-ethyl-N,N-diisopropylamine at 20℃; for 72h;24%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

tris(tetrabutylammonium) salt of the monoacid of imidodiphosphate

tris(tetrabutylammonium) salt of the monoacid of imidodiphosphate

triethylammonium salt of AMPNP
114635-41-5, 119447-18-6

triethylammonium salt of AMPNP

Conditions
ConditionsYield
With imidodiphosphate; triethylamine carbonate In acetonitrile at 25℃; for 24h;22%
potassium selenocyanate
3425-46-5

potassium selenocyanate

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5′-deoxyadenosinyl-5′-selenocyanate

5′-deoxyadenosinyl-5′-selenocyanate

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 11h; Inert atmosphere; Milling;20%
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

tris(tetrabutylammonium) salt of the monoacid of imidodiphosphate

tris(tetrabutylammonium) salt of the monoacid of imidodiphosphate

5'-imidodiphosphate-Adenosine
32476-54-3

5'-imidodiphosphate-Adenosine

Conditions
ConditionsYield
With imidodiphosphate In acetonitrile at 25℃; for 24h;
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

ethylenediamine
107-15-3

ethylenediamine

5'-<(2-aminoethyl)amino>-5'-deoxyadenosine
81090-72-4

5'-<(2-aminoethyl)amino>-5'-deoxyadenosine

Conditions
ConditionsYield
for 168h; Ambient temperature;
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Tributyl-amine; compound with GENERIC INORGANIC NEUTRAL COMPONENT

Tributyl-amine; compound with GENERIC INORGANIC NEUTRAL COMPONENT

Thiophosphoric acid S-[(2S,3S,4R,5R)-5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester; compound with tributyl-amine

Thiophosphoric acid S-[(2S,3S,4R,5R)-5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester; compound with tributyl-amine

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 24h; Ambient temperature; Yield given;
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5'-deoxy-5'-(thiocyanato)adenosine

5'-deoxy-5'-(thiocyanato)adenosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 96 percent / potassium carbonate / dimethylformamide / 15 h / 50 °C
2: 80 percent / methanol / 15 h / 20 °C
View Scheme
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

2',3'-didehydro-2',3'-dideoxyadenosine
7057-48-9

2',3'-didehydro-2',3'-dideoxyadenosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / pyridine / 5 h
2: 55 percent / sodium naphthalenide / tetrahydrofuran / -50 °C
View Scheme
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

5'-deoxy-5'-thioadenosine-5'-triphosphate

5'-deoxy-5'-thioadenosine-5'-triphosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide / 24 h / Ambient temperature
2: 1.) N,N'-carbonyldiimidazole, n-Bu3N, 2.) methanol, tri-n-butylammonium pyrophosphate / 1.) DMF, rt, 4 h, 2.) DMF, rt, 20 h
View Scheme
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

({[(3aR,4R,6R,6aR)-6-(6-Amino-purin-9-yl)-2-ethoxy-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethoxy]-hydroxy-phosphoryl}-difluoro-methyl)-phosphonic acid

({[(3aR,4R,6R,6aR)-6-(6-Amino-purin-9-yl)-2-ethoxy-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethoxy]-hydroxy-phosphoryl}-difluoro-methyl)-phosphonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 65 percent / dimethylsulfoxide / 1 h
2: CF3CO2H / dimethylsulfoxide
View Scheme

5135-30-8Relevant articles and documents

The nucleoside transport proteins, NupC and NupG, from Escherichia coli: Specific structural motifs necessary for the binding of ligands

Patching, Simon G.,Baldwin, Stephen A.,Baldwin, Alexander D.,Young, James D.,Gallagher, Maurice P.,Henderson, Peter J. F.,Herbert, Richard B.

, p. 462 - 470 (2007/10/03)

A series of 46 natural nucleosides and analogues (mainly adenosine-based) were tested as inhibitors of [U-14C]uridine uptake by the concentrative, H+-linked nucleoside transport proteins NupC and NupG from Escherichia coli. The two evolutionarily unrelated transporters showed similar but distinct patterns of inhibition, revealing differing selectivities for the different nucleosides and their analogues. Binding of nucleosides to NupG required the presence of hydroxyl groups at each of the C-3′ and C-5′ positions of ribose, while binding to NupC required only the C-3′ hydroxyl substituent. The greater importance of the ribose moiety for binding to NupG is consistent with the evolutionary relationship between this protein and the oligosaccharide: H+ symporter (OHS) subfamily of the major facilitator superfamily (MFS) of transporters. For both proteins the natural α-configuration at C-3′ and the natural β-configuration at C-1′ was mandatory for ligand binding. N-7 in the imidazole ring of adenosine and the amino group at C-6 were found not to be important for binding and both transporters showed flexibility for substitution at C-6/N6; one or both of N-l and N-3 were important for adenosine analogue binding to NupC but significantly less so for binding to NupG. From the different effects of 8-bromoadenosine on the two transporters it appears that adenosine selectively binds to NupC in an anti- rather than a syn-conformation, whereas NupG is less prescriptive. The pattern of inhibition of NupC by differing nucleoside analogues confirmed the functional relationship of the bacterial transporter to members of the human concentrative nucleoside transporter (CNT) family and reaffirmed the use of the bacterial protein as an experimental model for these physiologically and clinically important mammalian proteins. The specificity data for NupG have been used to develop a homology model of the protein's binding site, based on the X-ray crystallographic structure of the disaccharide transporter LacY from E. coli. We have also developed an efficient general protocol for the synthesis of adenosine and three of its analogues, which is illustrated by the synthesis of [1′-13C]adenosine.

The reaction of phenylboronic acid with nucleosides and mononucleotides.

Yurkevich,Kolodkina,Varshavskaya,Borodulina-Shvetz,Rudakova,Preobrazhenski

, p. 477 - 484 (2007/10/04)

-

On the thio ether and S-oxide derivatives of adenosine

Kuhn,Jahn

, p. 1699 - 1704 (2007/10/04)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5135-30-8